Bayer AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000BAY0017
EUR
39.59
0.99 (2.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
13,405.00
11,438.00
9,660.00
10,739.00
13,738.00
11,729.00
9,968.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
13,405.00
11,438.00
9,660.00
10,739.00
13,738.00
11,729.00
9,968.00
Raw Material Cost
5,232.00
4,501.00
4,307.00
4,364.00
5,625.00
5,723.00
5,090.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
2,811.00
3,100.00
2,622.00
2,976.00
3,027.00
3,216.00
3,145.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
679.00
675.00
762.00
495.00
584.00
703.00
642.00
Selling and Distribution Expenses
3,642.00
3,830.00
3,294.00
3,382.00
3,582.00
3,803.00
3,459.00
Other Expenses
-207.10
-237.00
-188.60
-206.30
-215.30
-219.40
-222.80
Total Expenditure (Excl Depreciation)
10,293.00
9,736.00
9,099.00
9,154.00
10,665.00
11,251.00
10,108.00
Operating Profit (PBDIT) excl Other Income
3112
1702
561
1585
3073
478
-140
Other Income
496.00
-693.00
71.00
-489.00
-105.00
584.00
559.00
Operating Profit (PBDIT)
4,862.00
1,343.00
1,637.00
1,368.00
4,142.00
1,873.00
1,403.00
Interest
679.00
675.00
762.00
495.00
584.00
703.00
642.00
Exceptional Items
47.00
-3,675.00
-1,045.00
-1,002.00
-552.00
-790.00
-4,091.00
Gross Profit (PBDT)
8,173.00
6,937.00
5,353.00
6,375.00
8,113.00
6,006.00
4,878.00
Depreciation
1,254.00
334.00
1,005.00
272.00
1,174.00
811.00
984.00
Profit Before Tax
2,976.00
-3,341.00
-1,175.00
-401.00
1,832.00
-431.00
-4,314.00
Tax
222.00
378.00
-202.00
-236.00
526.00
-153.00
-153.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,763.00
-3,757.00
-963.00
-199.00
1,299.00
-335.00
-4,183.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,763.00
-3,757.00
-963.00
-199.00
1,299.00
-335.00
-4,183.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.00
7.00
4.00
9.00
5.00
7.00
-11.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,767.00
-3,750.00
-959.00
-190.00
1,304.00
-328.00
-4,194.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
28,845.00
25,947.00
29,578.00
30,370.00
32,447.00
31,908.00
30,559.00
Earnings per share (EPS)
2.81
-3.82
-0.98
-0.2
1.32
-0.34
-4.26
Diluted Earnings per share
2.81
-3.82
-0.98
-0.2
1.32
-0.34
-4.26
Operating Profit Margin (Excl OI)
23.22%
14.88%
5.81%
14.76%
22.37%
4.08%
-1.4%
Gross Profit Margin
31.56%
-26.29%
-1.76%
-1.2%
21.88%
3.24%
-33.41%
PAT Margin
20.61%
-32.85%
-9.97%
-1.85%
9.46%
-2.86%
-41.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is -2.42% vs -0.20% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 112.19% vs -34.87% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 2.80% vs -2.61% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 16.27% vs -9.88% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Bayer AG With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
13,405.00
5,134.00
8,271.00
161.10%
Other Operating Income
0.00
0.00
0.00
Total Operating income
13,405.00
5,134.00
8,271.00
161.10%
Raw Material Cost
5,232.00
2,069.00
3,163.00
152.88%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
2,811.00
0.00
2,811.00
Power Cost
0
0
0.00
Manufacturing Expenses
679.00
104.00
575.00
552.88%
Selling and Distribution Expenses
3,642.00
1,415.00
2,227.00
157.39%
Other Expenses
-207.10
55.40
-262.50
-473.83%
Total Expenditure (Excl Depreciation)
10,293.00
4,142.00
6,151.00
148.50%
Operating Profit (PBDIT) excl Other Income
3,112.00
992.00
2,120.00
213.71%
Other Income
496.00
88.00
408.00
463.64%
Operating Profit (PBDIT)
4,862.00
1,577.00
3,285.00
208.31%
Interest
679.00
104.00
575.00
552.88%
Exceptional Items
47.00
-108.00
155.00
143.52%
Gross Profit (PBDT)
8,173.00
3,065.00
5,108.00
166.66%
Depreciation
1,254.00
497.00
757.00
152.31%
Profit Before Tax
2,976.00
869.00
2,107.00
242.46%
Tax
222.00
200.00
22.00
11.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,763.00
660.00
2,103.00
318.64%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,763.00
660.00
2,103.00
318.64%
Share in Profit of Associates
0
0
0.00
Minority Interest
4.00
9.00
-5.00
-55.56%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,767.00
669.00
2,098.00
313.60%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
28,845.00
29,742.00
-897.00
-3.02%
Earnings per share (EPS)
2.81
1.52
1.29
84.87%
Diluted Earnings per share
2.81
1.52
1.29
84.87%
Operating Profit Margin (Excl OI)
23.22%
19.32%
0.00
3.90%
Gross Profit Margin
31.56%
26.61%
0.00
4.95%
PAT Margin
20.61%
12.86%
0.00
7.75%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,340.50 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 17.20% vs 18.41% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -2.42% vs -0.20% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 276.70 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 173.79% vs -291.03% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 112.19% vs -34.87% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 436.60 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 114.44% vs 30.01% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 2.80% vs -2.61% in Mar 2025

Quarterly - Interest
Interest 67.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.59% vs -11.42% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 16.27% vs -9.88% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.22%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025